Dr. Melyssa Bratton is a molecular biochemist and clinical research leader specializing in translational oncology and biospecimen science. Her early work in breast cancer focused on endocrine resistance and the impact of environmental factors on tumor biology, while her current research emphasizes clinical outcomes and the integration of biospecimens into studies of cancer detection and treatment response. As manager of the Biospecimen and Core Research Laboratory at Ochsner Health, she leads efforts to support multidisciplinary clinical research and precision medicine initiatives.